Multi-centre randomised self-controlled trial comparing standard of care (SoC) with and without the geko™ device in patients with hard-to-heal venous...
Innovating Care in Machine Learning Phoenix Children’s Hospital Executive Vice President and Chief Innovation Officer David Higginson offered his insights...
Small molecule neoantigen immuno-oncology company NeoPhore has signed a strategic collaboration agreement with Professor Chris Lord’s lab at The Institute...